Zealand Pharma A/S (ZEAL)

Over the past 90 days, Zealand Pharma A/S recorded a single insider transaction involving a sale of 278,000 DKK by an employee-elected board member. This follows a period where the stock price declined by 6.6%. The company's most recent earnings report in May 2026 showed an EPS beat of 39.08%.
Ticker: ZEAL Exchange: CPH


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Zealand Pharma A/S. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 16 Jul 2026
Value DKK4,399,818.16 | Price 171.62 | Shares 35,046
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-20 2026-07-16 S Sale

Member of the Board of Directors

Executive Director
35,046
171.62
DKK4,399,818
35,046 171.62 DKK4,399,818
2026-06-22 2026-06-17 S Sale

Employee elected Board Member

Director
40,251
481.15
DKK2,020,930
40,251 481.15 DKK2,020,930
2025-12-19 2025-12-18 S Sale

Chief Financial Officer

Officer
92,542
198.58
DKK2,086,550
92,542 198.58 DKK2,086,550
2025-12-19 2025-12-18 S Sale

Employee elected member of the Board of Directors

Executive Director
650
462.00
DKK300,300
650 462.00 DKK300,300
2025-12-19 2025-12-17 S Sale

Employee elected member of the Board of Directors

Executive Director
141
460.57
DKK64,940
141 460.57 DKK64,940
2025-12-19 2025-12-17 S Sale

Chairman of the Board of Directors

Executive Director
1,700
467.00
DKK793,900
1,700 467.00 DKK793,900